FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016726396> ?p ?o ?g. }

• W2016726396 endingPage "939" @default.
• W2016726396 startingPage "933" @default.
• W2016726396 abstract "BackgroundThe aim of this study was to observe the effects of neoadjuvant therapy with irinotecan and5-fluorouracil (5-FU)/folinic acid (FA) on the resection rate and survival of colorectal cancer patients with initially unresectable hepatic metastases.Patients and methodsForty patients received neoadjuvant chemotherapy comprising irinotecan 180 mg/m2 administered intravenously (i.v.) on day 1, FA 200 mg/m2 i.v. on days 1 and 2, 5-FU 400 mg/m2 i.v. bolus on days 1 and 2, and 5-FU 1200 mg/m2 as a continuous 48-h i.v. infusion on day 1. The treatment was repeated every 2 weeks and response was assessed every 12 weeks (six cycles).ResultsThe objective response rate to chemotherapy was 47.5% (n = 19), with two complete responses and disease stabilization in 11 (27.5.%) patients. Responses were unconfirmed for 11 patients undergoing surgery within 2 weeks. Treatment was well tolerated and adverse events were typical of the chemotherapy agents used. Twenty-seven (67.5%) patients reported hematological toxicity (35.0% grade 3/4) and 14 (35.0%) reported gastrointestinal toxicity (12.5% grade 3/4). Thirteen patients (32.5%) underwent potentially curative liver resection following chemotherapy. Chemotherapy was particularly effective in patients with large metastases on entry to the study. The median time to progression is 14.3 months and, at a median follow-up of 19 months, all patients are alive.ConclusionsNeoadjuvant therapy with irinotecan combined with 5-FU/FA enabled a significant proportion of patients with initially unresectable liver metastases to undergo surgical resection. The effects of treatment on survival have yet to be determined." @default.
• W2016726396 created "2016-06-24" @default.
• W2016726396 creator A5006457492 @default.
• W2016726396 creator A5012446712 @default.
• W2016726396 creator A5015435907 @default.
• W2016726396 creator A5023798303 @default.
• W2016726396 creator A5032909786 @default.
• W2016726396 creator A5035856942 @default.
• W2016726396 creator A5037327785 @default.
• W2016726396 creator A5065423403 @default.
• W2016726396 creator A5080721675 @default.
• W2016726396 creator A5080802426 @default.
• W2016726396 date "2004-06-01" @default.
• W2016726396 modified "2023-09-30" @default.
• W2016726396 title "Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients" @default.
• W2016726396 cites W1696496287 @default.
• W2016726396 cites W1848603902 @default.
• W2016726396 cites W1969825132 @default.
• W2016726396 cites W1976966111 @default.
• W2016726396 cites W2007615142 @default.
• W2016726396 cites W2024082570 @default.
• W2016726396 cites W2026634337 @default.
• W2016726396 cites W2028456177 @default.
• W2016726396 cites W2045066689 @default.
• W2016726396 cites W2051224942 @default.
• W2016726396 cites W2060515114 @default.
• W2016726396 cites W2067482493 @default.
• W2016726396 cites W2104256009 @default.
• W2016726396 cites W2121368761 @default.
• W2016726396 cites W2128447158 @default.
• W2016726396 cites W2133399075 @default.
• W2016726396 cites W2146798192 @default.
• W2016726396 cites W2162313061 @default.
• W2016726396 cites W2171680834 @default.
• W2016726396 cites W2314927739 @default.
• W2016726396 cites W2324721854 @default.
• W2016726396 cites W2396646859 @default.
• W2016726396 cites W2468837473 @default.
• W2016726396 doi "https://doi.org/10.1093/annonc/mdh217" @default.
• W2016726396 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15151951" @default.
• W2016726396 hasPublicationYear "2004" @default.
• W2016726396 type Work @default.
• W2016726396 sameAs 2016726396 @default.
• W2016726396 citedByCount "299" @default.
• W2016726396 countsByYear W20167263962012 @default.
• W2016726396 countsByYear W20167263962013 @default.
• W2016726396 countsByYear W20167263962014 @default.
• W2016726396 countsByYear W20167263962015 @default.
• W2016726396 countsByYear W20167263962016 @default.
• W2016726396 countsByYear W20167263962017 @default.
• W2016726396 countsByYear W20167263962018 @default.
• W2016726396 countsByYear W20167263962019 @default.
• W2016726396 countsByYear W20167263962020 @default.
• W2016726396 countsByYear W20167263962021 @default.
• W2016726396 countsByYear W20167263962022 @default.
• W2016726396 countsByYear W20167263962023 @default.
• W2016726396 crossrefType "journal-article" @default.
• W2016726396 hasAuthorship W2016726396A5006457492 @default.
• W2016726396 hasAuthorship W2016726396A5012446712 @default.
• W2016726396 hasAuthorship W2016726396A5015435907 @default.
• W2016726396 hasAuthorship W2016726396A5023798303 @default.
• W2016726396 hasAuthorship W2016726396A5032909786 @default.
• W2016726396 hasAuthorship W2016726396A5035856942 @default.
• W2016726396 hasAuthorship W2016726396A5037327785 @default.
• W2016726396 hasAuthorship W2016726396A5065423403 @default.
• W2016726396 hasAuthorship W2016726396A5080721675 @default.
• W2016726396 hasAuthorship W2016726396A5080802426 @default.
• W2016726396 hasBestOaLocation W20167263961 @default.
• W2016726396 hasConcept C121608353 @default.
• W2016726396 hasConcept C126322002 @default.
• W2016726396 hasConcept C141071460 @default.
• W2016726396 hasConcept C2776694085 @default.
• W2016726396 hasConcept C2779804826 @default.
• W2016726396 hasConcept C2780259306 @default.
• W2016726396 hasConcept C2780456651 @default.
• W2016726396 hasConcept C526805850 @default.
• W2016726396 hasConcept C71924100 @default.
• W2016726396 hasConcept C90924648 @default.
• W2016726396 hasConceptScore W2016726396C121608353 @default.
• W2016726396 hasConceptScore W2016726396C126322002 @default.
• W2016726396 hasConceptScore W2016726396C141071460 @default.
• W2016726396 hasConceptScore W2016726396C2776694085 @default.
• W2016726396 hasConceptScore W2016726396C2779804826 @default.
• W2016726396 hasConceptScore W2016726396C2780259306 @default.
• W2016726396 hasConceptScore W2016726396C2780456651 @default.
• W2016726396 hasConceptScore W2016726396C526805850 @default.
• W2016726396 hasConceptScore W2016726396C71924100 @default.
• W2016726396 hasConceptScore W2016726396C90924648 @default.
• W2016726396 hasIssue "6" @default.
• W2016726396 hasLocation W20167263961 @default.
• W2016726396 hasLocation W20167263962 @default.
• W2016726396 hasOpenAccess W2016726396 @default.
• W2016726396 hasPrimaryLocation W20167263961 @default.
• W2016726396 hasRelatedWork W134396366 @default.
• W2016726396 hasRelatedWork W1965756961 @default.
• W2016726396 hasRelatedWork W1988411616 @default.
• W2016726396 hasRelatedWork W2003872607 @default.
• W2016726396 hasRelatedWork W2010991676 @default.

• next